Latest Breaking News On - Joshua bartch - Page 10 : comparemela.com

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesJoshua bartchTodd heinzlNational instrumentCompany the subscriber onCompany audit committeeAudit committeeBoard of directors the companyCommon share subscription agreementRobert roscow

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesJoshua bartchTodd heinzlMydecine innovations group incRobert roscowBlvd suite

Mydecine Innovations Group Announces Private Placement;

DENVER, Aug. 19, 2022 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a.

United statesDamon michaelsJoshua bartchTodd heinzlNational instrumentMydecine innovations group incCompany the subscriber onAudit committeeMydecine innovations groupCompany audit committeeBoard of directors the companyInnovations groupCommon share subscription agreementSubscription agreementRobert roscowLarry dean ditto

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesDamon michaelsJoshua bartchTodd heinzlNational instrumentMydecine innovations group incCompany the subscriber onAudit committeeMydecine innovations groupCompany audit committeeBoard of directors the companyInnovations groupCommon share subscription agreementSubscription agreementRobert roscowLarry dean ditto

Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022

16.08.2022 - DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ( Mydecine or the Company ), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today .

United statesDamon michaelsJoshua bartchMydecine innovations group incMydecine innovations groupNet lossInnovations groupChief operating officerChief executive officer